![Toby Capstick on X: "#Trelegy Ellipta: The second ICS/LAMA/LABA inhaler in the UK, licensed for #COPD. https://t.co/NSYtv7bTYS (An alternative ICS/LABA /LAMA inhaler is available: #Trimbow MDI) https://t.co/vQBgh9lvM2" / X Toby Capstick on X: "#Trelegy Ellipta: The second ICS/LAMA/LABA inhaler in the UK, licensed for #COPD. https://t.co/NSYtv7bTYS (An alternative ICS/LABA /LAMA inhaler is available: #Trimbow MDI) https://t.co/vQBgh9lvM2" / X](https://pbs.twimg.com/media/DPVNbspWkAErhbn.jpg)
Toby Capstick on X: "#Trelegy Ellipta: The second ICS/LAMA/LABA inhaler in the UK, licensed for #COPD. https://t.co/NSYtv7bTYS (An alternative ICS/LABA /LAMA inhaler is available: #Trimbow MDI) https://t.co/vQBgh9lvM2" / X
![Inhalers! This is a follow-up from one of last weeks posts about the triple inhaler. We have 5 total inhalers that are … | Inhaler, Nebulizers, Combination therapy Inhalers! This is a follow-up from one of last weeks posts about the triple inhaler. We have 5 total inhalers that are … | Inhaler, Nebulizers, Combination therapy](https://i.pinimg.com/originals/ea/ed/5f/eaed5fda66fdba0cfbfbab28d8c0ee08.jpg)
Inhalers! This is a follow-up from one of last weeks posts about the triple inhaler. We have 5 total inhalers that are … | Inhaler, Nebulizers, Combination therapy
![Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X](https://pbs.twimg.com/media/DtzVlWsWwAArrfB.jpg)
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
![Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram](https://www.researchgate.net/publication/332642841/figure/tbl2/AS:751585386848265@1556203328958/Principal-differences-between-inhaler-devices-used-to-deliver-LAMA-LABA-FDC.png)
Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001-550.jpg)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
![Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA/LABA/ICS combination. Though it was FDA approved 1 full … | Inhaler, Ambulatory care, Labas Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA/LABA/ICS combination. Though it was FDA approved 1 full … | Inhaler, Ambulatory care, Labas](https://i.pinimg.com/1200x/5e/3c/86/5e3c8631532e41f3d6120138f2f80739.jpg)
Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA/LABA/ICS combination. Though it was FDA approved 1 full … | Inhaler, Ambulatory care, Labas
![The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD | Pulmonary Therapy The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD | Pulmonary Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs41030-023-00233-z/MediaObjects/41030_2023_233_Figc_HTML.png)
The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD | Pulmonary Therapy
![實證醫學LAMA/LABA固定劑量組合吸入劑逐漸成為COPD治療主軸(LABA and LAMA in a combined inhaler versus placebo for COPD) - NEJS 實證醫學LAMA/LABA固定劑量組合吸入劑逐漸成為COPD治療主軸(LABA and LAMA in a combined inhaler versus placebo for COPD) - NEJS](https://1.bp.blogspot.com/-CRT07wUK_d4/XQQvFhKDnXI/AAAAAAAB2Og/-r-XFnw0TJUa1dFJuKaFFeYI_AG5qDacQCLcBGAs/s1600/NEJS%2B20141120.png)
實證醫學LAMA/LABA固定劑量組合吸入劑逐漸成為COPD治療主軸(LABA and LAMA in a combined inhaler versus placebo for COPD) - NEJS
![Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X](https://pbs.twimg.com/media/CytQ4InXEAAYpUe.jpg)
Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X
![Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia | HarDoctor News, il Blog di Carlo Cottone Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia | HarDoctor News, il Blog di Carlo Cottone](https://hardoctor.files.wordpress.com/2022/05/terapia-inalatoria-triplice-vs-doppia.jpg)
Asma bronchiale, con triplice terapia ICS+LABA+LAMA, meno esacerbazioni e più controllo della malattia | HarDoctor News, il Blog di Carlo Cottone
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)